Borg A - Search Results

1

Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.

Fernö M, Baldetorp B, Borg A, Olsson H, Sigurdsson H, Killander D. Fernö M, et al. Among authors: borg a. Acta Oncol. 1992;31(2):157-65. doi: 10.3109/02841869209088897. Acta Oncol. 1992. PMID: 1622630

2

c-myc amplification is an independent prognostic factor in postmenopausal breast cancer.

Borg A, Baldetorp B, Fernö M, Olsson H, Sigurdsson H. Borg A, et al. Int J Cancer. 1992 Jul 9;51(5):687-91. doi: 10.1002/ijc.2910510504. Int J Cancer. 1992. PMID: 1612775

3

ERBB2 amplification in breast cancer with a high rate of proliferation.

Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Sigurdsson H. Borg A, et al. Oncogene. 1991 Jan;6(1):137-43. Oncogene. 1991. PMID: 1671531

4

Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.

Borg A, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Olsson H, Killander D, McGurie WL. Borg A, et al. Br J Cancer. 1991 Jan;63(1):136-42. doi: 10.1038/bjc.1991.28. Br J Cancer. 1991. PMID: 1989653 Free PMC article.

5

Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels.

Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D, Olsson H, Ranstam J. Sigurdsson H, et al. Among authors: borg a. Br J Cancer. 1990 Nov;62(5):786-90. doi: 10.1038/bjc.1990.380. Br J Cancer. 1990. PMID: 2245171 Free PMC article.

6

Indicators of prognosis in node-negative breast cancer.

Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D, Olsson H. Sigurdsson H, et al. Among authors: borg a. N Engl J Med. 1990 Apr 12;322(15):1045-53. doi: 10.1056/NEJM199004123221505. N Engl J Med. 1990. PMID: 2320064 Free article.

7

Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study Group.

Fernö M, Borg A, Johansson U, Norgren A, Olsson H, Rydén S, Sellberg G. Fernö M, et al. Among authors: borg a. Acta Oncol. 1990;29(2):129-35. doi: 10.3109/02841869009126532. Acta Oncol. 1990. PMID: 2334566

8

Enzyme immunoassay of progesterone receptor in breast cancer biopsy samples. A comparison with the dextran coated charcoal method.

Fernö M, Borg A, Johansson U. Fernö M, et al. Among authors: borg a. Acta Oncol. 1989;28(1):19-22. doi: 10.3109/02841868909111175. Acta Oncol. 1989. PMID: 2468353

9

Estrogen receptor enzyme immunoassay in fine-needle aspirates from human breast cancer.

Borg A, Fernö M, Idvall I. Borg A, et al. Acta Oncol. 1989;28(2):187-91. doi: 10.3109/02841868909111245. Acta Oncol. 1989. PMID: 2660861

10

Early oral contraceptive use as a prognostic factor in breast cancer.

Olsson H, Möller TR, Ranstam J, Borg A, Fernö M. Olsson H, et al. Among authors: borg a. Anticancer Res. 1988 Jan-Feb;8(1):29-32. Anticancer Res. 1988. PMID: 3358638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

855 results

Search Page

Filters